Applied UV (NASDAQ:AUVI) Issues Quarterly Earnings Results

Applied UV (NASDAQ:AUVIGet Rating) issued its quarterly earnings data on Monday. The company reported ($0.16) earnings per share for the quarter, hitting the consensus estimate of ($0.16), MarketWatch Earnings reports. Applied UV had a negative return on equity of 32.67% and a negative net margin of 63.34%. During the same quarter in the previous year, the company earned ($0.11) EPS.

AUVI opened at $0.97 on Friday. The stock has a market cap of $12.54 million, a price-to-earnings ratio of -1.13 and a beta of 0.71. The stock’s 50 day moving average price is $1.31 and its 200-day moving average price is $2.42. Applied UV has a one year low of $0.87 and a one year high of $12.15.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its holdings in shares of Applied UV by 426.7% in the first quarter. Renaissance Technologies LLC now owns 70,831 shares of the company’s stock valued at $106,000 after purchasing an additional 57,384 shares during the period. Advisor Group Holdings Inc. boosted its holdings in shares of Applied UV by 74.8% in the first quarter. Advisor Group Holdings Inc. now owns 75,804 shares of the company’s stock valued at $114,000 after purchasing an additional 32,440 shares during the period. Citadel Advisors LLC purchased a new stake in shares of Applied UV in the second quarter valued at approximately $144,000. Morgan Stanley purchased a new stake in shares of Applied UV in the second quarter valued at approximately $51,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Applied UV by 12.4% in the third quarter. Geode Capital Management LLC now owns 29,111 shares of the company’s stock valued at $206,000 after purchasing an additional 3,204 shares during the period. 2.47% of the stock is currently owned by hedge funds and other institutional investors.

About Applied UV (Get Rating)

Applied UV, Inc, through its subsidiaries, engages in the development, acquisition, and commercialization of technology that address air and surface purification, and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States and Canada. The company offers science-based solutions and products in air purification under the Airocide brand; and disinfection of hard surfaces under the Lumicide brand.

Featured Stories

Earnings History for Applied UV (NASDAQ:AUVI)

Receive News & Ratings for Applied UV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied UV and related companies with MarketBeat.com's FREE daily email newsletter.